Pfizer Portugal

To achieve our commitment to people's health and well-being, at Pfizer we dedicate an important investment in research and development of innovative responses to combat the most critical diseases of our time.

Today we live in unique moments in biomedical innovation. More than a decade after the decoding of the human genome, we have a better understanding of human biology and the causes of disease.

We have learned that it takes more than great science to be able to provide new potential therapies that make a difference. Over the past few years, Pfizer has adopted a more integrated, collaborative and focused approach, aiming to deliver a sustainable pipeline of new medicines and vaccines. We focus on intervening in areas that represent important health needs such as inflammation and pain, cardiovascular diseases, oncology, immunological and metabolic diseases and vaccines.